— NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act —
WASHINGTON, D.C., June 15, 2023 — Today the Senate Committee on Health, Education, Labor and Pensions (HELP) passed the bipartisan NAPA Reauthorization Act (S. 133 / H.R. 619) and the Alzheimer’s Accountability and Investment Act (S. 134 / H.R. 620). The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support these critical bills that will grow momentum in the fight against Alzheimer’s and all other dementia.
“The NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act will build on the progress made over the last decade and renew our nation’s commitment to addressing the growing Alzheimer’s crisis,” said Robert Egge, Alzheimer’s Association chief public policy officer and AIM executive director. “Thank you to the HELP Committee Chair Bernie Sanders, Ranking Member Bill Cassidy, lead sponsors Sens. Susan Collins and Ed Markey, and the committee members for supporting these critical bills today. AIM and the Alzheimer’s Association remain deeply committed to building bipartisan support for the NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act, which will improve the lives of those impacted by Alzheimer’s and other dementia.”
The NAPA Reauthorization Act would extend the National Alzheimer’s Project Act (NAPA) (P.L. 111-375), a landmark piece of legislation signed into law in 2011, which led the way for additional policy victories and fundamentally changed the way our nation addresses Alzheimer’s and other dementia.
The Alzheimer’s Accountability and Investment Act builds on the original Alzheimer’s Accountability Act, which was first enacted in 2014, to ensure Congress continues to hear directly from scientists at the National Institutes of Health (NIH) on what resources are needed to prevent and effectively treat Alzheimer's disease.
With NAPA and the original Alzheimer’s Accountability Act set to expire in 2025, updated legislation is urgently needed. First introduced in the 117th Congress, AIM advocates from across the nation have been working to build bipartisan support for these critical bills, and remain deeply committed to swiftly passing them into law.
The NAPA Reauthorization Act was introduced by Sens. Susan Collins (R-Maine), Mark Warner (D-Va.), Shelly Moore Capito (R-W.Va.), Ed Markey (D-Mass.), Jerry Moran (R-Kan.), Bob Menendez (D-N.J.), Lisa Murkowski (R-Alaska) and Debbie Stabenow (D-Mich.) in the Senate, and Reps. Paul Tonko (D-N.Y), Chris Smith (R-N.J) and Maxine Waters (D-Calif.) in the House. The Alzheimer’s Accountability and Investment Act was introduced by Sens. Susan Collins (R-Maine), Ed Markey (D-Mass.), Shelley Moore Capito (R-W.Va.), Mark Warner (D-Va.), Jerry Moran (R-Kan.), Bob Menendez (D-N.J.), Lisa Murkowski (R-Alaska) and Debbie Stabenow (D-Mich.) in the Senate, and Reps. Chris Smith (R-N.J.), Paul Tonko (D-N.Y.) and Maxine Waters (D-Calif.) in the House.
About the Alzheimer's Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.
Alzheimer’s Impact Movement
The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM works to develop and advance policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.